IASB Welcomes New Recommendations of the U.S. Government for Biosecurity in Synthetic Gene Production
News Dec 14, 2009
Recently the U.S. Government published recommendations for the production of synthetic genes. Those recommendations have been requested by associations like the International Association Synthetic Biology. The fast development in the field of synthetic genes as a powerful tool in modern biotechnology necessitates a control to assure that opportunities can be taken and risks are minimized.
The recommendations are intended to provide guidance to producers of synthetic genomic products regarding the screening of orders, and encourage best practices in addressing any potential biosecurity concerns. The U.S. Government recommends that all orders for synthetic double-stranded DNA 200 base pairs (bp) in length or longer be subject to a screening framework that includes both sequence screening and customer screening.
Only a few weeks ago the IASB enacted a code of conduct for a save use of gene synthesis. This contains in addition to basic aspects (screening, records, transparency) best practices like a specialized database (VIREP) which enables the inspection of orders for synthetic genes regarding pathogen or virulent sequences and appropriate software (Blackwatch from Craig Computing).
The IASB’s code of conduct addresses next to companies in the field of synthetic genes academic institutes and public institutions.
The code of conduct and the recommendations of the IASB raised high interest. Within the scope of the further development the IASB is implementing an international “Technical Expert Group Biosecurity” which can advice members of the IASB as well as other interested parties.
Peer Staehler, CSO at febit and member of the IASB board, said: “We appreciate the initiative of the U.S. Government and hope that other countries will follow suit and implement recommendations for the handling and business with synthetic genes. We invite all companies and institutions in the field of synthetic biology to join the IASB and use the VIREP database. A certificate of the IASB can be a way for companies to show their sense of responsibility in this highly sensitive market.”
Largest Genetic Study of Osteoarthritis Advances ResearchNews
Osteoarthritis is a complex disease, and the genetic basis of the disease has proved difficult to pin down. A new study from the Sanger Institute provides much-needed hope.READ MORE
The DNA Shuffle: Barcoding Trick is Boost to RNA-SeqNews
SPLiT-seq is a new technology that can separate thousands of cells using innovative barcoding technology.READ MORE
Comments | 0 ADD COMMENT
11th International Conference and Exhibition on Metabolomics & Systems Biology
May 17 - May 19, 2018
6th Annual Congress on Biology and Medicine of Molecules
Sep 17 - Sep 18, 2018
World Congress on Pathology and Laboratory Medicine
Sep 10 - Sep 11, 2018